Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 1/2 3Phase 3 2Phase 2/3 2Phase 1 1

Status

Recruiting 4Not yet recruiting 3Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Tumor-Agnostic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2

Interventions

Standard of Care 25Exercise 24Interviews as Topic 19Blood Specimen Collection 18Educational Status 13Methods 12Surgical Procedures, Operative 11Drug Therapy 11Surveys and Questionnaires 10Radiosurgery 10Specimen Handling 9Saline Solution 9Acupuncture Therapy 9Paclitaxel 8Early Intervention, Educational 8Therapeutics 7Radiotherapy 7Magnetic Resonance Spectroscopy 7Electroacupuncture 7Cryotherapy 7Resistance Training 6Preoperative Exercise 6Practice Guidelines as Topic 6Palliative Care 6Dexmedetomidine 6Control Groups 6Colonoscopy 6Carboplatin 6tislelizumab 5Sentinel Lymph Node Biopsy 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × blinatumomab × Clear all
NCT07443592 2026-03-02

LAL-2025

PETHEMA Foundation

Phase NA Not yet recruiting
330 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06991920 2026-02-11

Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Not yet recruiting
50 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06763302 2025-01-08

NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL

The Children's Hospital of Zhejiang University School of Medicine

Phase NA Not yet recruiting
1,220 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡